/

DCOY

Decoy Therapeutics Inc.Closed

1.24−0.19 −13.29%USD

NasdaqCM · as of Oct 13, 16:00 ET · 15m delayAfter hours 1.24 +0.28%

Open

1.40

Prev close

1.43

Day range

1.211.40

52-week range

1.2155.92

Volume

166.73K0.08×

Mkt cap

2.96M

P/E ttm

0.11

Fwd P/E

-0.15

EPS ttm

11.32

Div yield

0.00%

Earnings

—

From 52w high

−97.78%

Price Chart

Yahoo Finance · delayed

DCOYOct 13, 2026O 1.40H 1.40L 1.21C 1.24−0.19 (−13.29%)Vol 166.70K

SMA 502.85
SMA 2006.03

1Y change −97.39% since Oct 13, 2025 close539 bars loadedTimes in America/New_YorkDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

DCOY Decoy Therapeutics Inc. · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: −20.00%
1 month: −53.56%
3 months: −78.43%
6 months: −80.00%
Year to date: −84.08%
1 year: −97.39%

Valuation & ownership

Market cap: 2.96M
Enterprise value: −7.48M
P/E (ttm): 0.11
Forward P/E: -0.15
PEG ratio: —
Price / book: 0.15
Price / sales (ttm): 12.99
EV / EBITDA: 1.23
EPS (ttm): 11.32
EPS (forward): -8.28
Beta (5y monthly): 0.64
Dividend yield: 0.00%
Payout ratio: 0.00%
Shares outstanding: 2.39M
Float: 586.44K
Short % of float: 23.05%
Short ratio (days): 0.02
Held by insiders: 10.44%
Held by institutions: 9.67%
Avg volume (3m): 2.20M
50-day average: 2.91
200-day average: 6.06
52-week change: −97.39%
S&P 500 52-week: +17.03%

Technicals (daily)

RSI (14): oversold 27.0
vs 50-day SMA: −56.53%
vs 200-day SMA: −79.44%
50 / 200-day trend: ▼ 50 below 200
MACD vs signal: ▼ below
ATR (14) % of price: 32.55%
Realised vol (20d, ann.): 181.9%
From 52-week high: −97.78%
From 52-week low: +2.48%

ANR

Analyst Consensus

1 analysts

Consensus

Strong buy

1.00 on a 1 (strong buy) – 5 (sell) scale

Mean target

3.00

+141.94% implied

Low 3.00Median 3.00High 3.00

Recommendation trend

Now1 / 0 / 0

Buy / hold / sell counts

Financial Snapshot

Full statements →

DES

About Decoy Therapeutics Inc.

Yahoo Finance profile

Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company. It focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that leverages peptide coiled-coils chemistry and physics to design a-helical peptides through computational and ML tools. The company's IMP3ACT platform leverages machine learning and artificial intelligence tools alongside synthesis techniques to engineer, enhance, and manufacture peptide conjugates targeting various unmet medical needs. It focuses on building a portfolio of peptide conjugate therapeutics focusing on infectious diseases and oncology. The company was formerly known as Salarius Pharmaceuticals, Inc. and change its name to Decoy Therapeutics Inc. in January 2026. Decoy Therapeutics Inc. is based in Houston, Texas.

Sector: Healthcare
Industry: Biotechnology
Employees: 11
Headquarters: Houston, TX, United States
Website: decoytx.com
Officers: Mr. Frederick E. Pierce II CEO & Director
Mr. Mark J. Rosenblum CPA Executive VP of Finance & CFO
Dr. Barbara Hibner Ph.D. Chief Scientific Officer
Mr. Peter K. Marschel M.B.A., M.S. Chief Business Officer

SEAS

Seasonality · DCOY

2015–2026 · monthly returns

Strongest month Jan +1.66%Weakest month Jul −13.63%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	18.8	-11.7	-20.1	-7.4	47.4	-19.4	-42.8	-25.8	-35.4	-37.1			−84.1%
2025	21.7	-51.8	-30.2	-5.8	7.5	17.4	-33.1	-35.9	-36.3	6.0	-75.8	-31.0	−97.6%
2024	-15.5	22.0	-21.0	-5.7	-7.2	-35.7	7.6	-35.2	-13.3	11.8	-11.2	28.7	−64.6%
2023	68.6	-17.6	-10.1	-6.8	-20.8	5.7	-38.3	-4.2	-25.2	27.4	-14.3	-9.5	−57.5%
2022	-9.3	-11.1	-0.5	-49.2	-10.9	16.7	-9.5	5.8	-3.0	-58.4	-4.9	-20.7	−87.7%
2021	22.0	62.2	-17.8	-13.5	0.0	-17.2	-23.5	28.2	-1.9	-18.8	-21.5	-23.7	−45.5%
2020	-33.9	-64.6	-23.1	21.9	19.3	33.3	-12.9	-18.3	-10.2	-23.3	5.1	33.8	−75.9%
2019	-4.8	6.1	15.9	18.7	4.1	15.9	-46.0	14.1	-36.0	-14.7	-14.0	-5.5	−54.2%
2018	18.3	-0.7	22.0	-4.0	-20.8	-75.3	-11.3	-40.6	-6.1	12.9	-18.1	-23.3	−90.5%
2017	-17.4	-4.4	5.5	-21.8	2.0	9.7	10.4	-7.5	-13.2	-19.6	52.9	-16.7	−33.9%
2016	-33.2	-10.7	47.6	-0.1	14.1	-18.4	16.1	-6.6	6.4	-58.7	26.5	-14.1	−57.6%
2015		17.9	12.7	-14.7	6.8	-3.6	-9.4	-22.8	-0.2	-5.7	6.8	2.9	−15.5%

INSD

Insider Activity · DCOY

Market-wide insider buying →Congress trades →SEC Form 4 filings via Yahoo Finance

Buys, 6 months

0 shares

Sells, 6 months

— shares

Net shares

Net change in insider shares

—

Date	Insider	Transaction	Shares	Value
Aug 30, 2026	Marschel Peter KlausOfficer	Stock Award(Grant) at price 0.00 per share.	3.9K	—
Aug 30, 2026	Hibner Barbara Louise Ph.D.Officer	Stock Award(Grant) at price 0.00 per share.	4.2K	—
Aug 30, 2026	Gauthier Patricia G.Director	Stock Award(Grant) at price 0.00 per share.	2K	—
Aug 30, 2026	Rosenblum Mark JChief Financial Officer	Stock Award(Grant) at price 0.00 per share.	9.7K	—
Aug 30, 2026	Hanish Arnold CDirector	Stock Award(Grant) at price 0.00 per share.	3K	—
Aug 30, 2026	Lammers Paul IDirector	Stock Award(Grant) at price 0.00 per share.	2K	—
Aug 30, 2026	Pierce Frederick E IiChief Executive Officer	Stock Award(Grant) at price 0.00 per share.	33.5K	—
Aug 30, 2026	Lieber Jonathan IDirector	Stock Award(Grant) at price 0.00 per share.	2K	—
Aug 30, 2026	Mcvicar William KennethDirector	Stock Award(Grant) at price 0.00 per share.	3K	—
Aug 30, 2026	Burleson TessDirector	Stock Award(Grant) at price 0.00 per share.	2K	—
Dec 29, 2025	Hanish Arnold CDirector	Sale at price 0.64 per share.	27	$17
Nov 19, 2025	Rosenblum Mark JChief Financial Officer	Purchase at price 0.80 per share.	20K	$16.00K
Nov 19, 2025	Hanish Arnold CDirector	Purchase at price 0.75 per share.	5K	$3.74K

DCOY

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

DCOY

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

Financial Snapshot

About Decoy Therapeutics Inc.

Seasonality · DCOY

Insider Activity · DCOY

Congress Trades · DCOY

Investors Holding DCOY

Investors Holding DCOY

Congress Trades · DCOY

Insider Activity · DCOY

Seasonality · DCOY

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

Financial Snapshot

About Decoy Therapeutics Inc.

Earnings & Dividends

News